The significant growth in investment value over 20 years, coupled with an average annual return that substantially outperforms the market, highlights Regeneron Pharmaceuticals' strong financial performance and potential for continued growth. This historical performance is likely to positively influence investor perception and could lead to increased investor interest and potentially higher stock prices in the short term.